Cargando…
Independent Evaluation of the Respective Predictive Values for High-Grade Prostate Cancer of Clinical Information and RNA Biomarkers after Upfront MRI and Image-Guided Biopsies
Upfront MRI is taking the lead in the diagnosis of clinically significant prostate cancer, while few image-guided biopsies (IGBs) fail to demonstrate clinically significant prostate cancer. The added value of innovative biomarkers is not confirmed in this context. We analysed SelectMDx-v2 (MDx-2) in...
Autores principales: | Roumiguié, Mathieu, Ploussard, Guillaume, Nogueira, Léonor, Bruguière, Eric, Meyrignac, Olivier, Lesourd, Marine, Péricart, Sarah, Malavaud, Bernard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072157/ https://www.ncbi.nlm.nih.gov/pubmed/31991591 http://dx.doi.org/10.3390/cancers12020285 |
Ejemplares similares
-
Assessment of the Minimal Targeted Biopsy Core Number per MRI Lesion for Improving Prostate Cancer Grading Prediction
por: Ploussard, Guillaume, et al.
Publicado: (2020) -
Confirmation by Early Oncologic Outcomes After Surgery of the Accuracy of Intermediate-risk Prostate Cancer Classification Based on Magnetic Resonance Imaging Staging and Targeted Biopsy
por: Manceau, Cécile, et al.
Publicado: (2020) -
MRI Characteristics Accurately Predict Biochemical Recurrence after Radical Prostatectomy
por: Manceau, Cécile, et al.
Publicado: (2020) -
Biochemical recurrence-free survival and pathological outcomes after radical prostatectomy for high-risk prostate cancer
por: Beauval, Jean-Baptiste, et al.
Publicado: (2016) -
Timing and delay of radical prostatectomy do not lead to adverse oncologic outcomes: results from a large European cohort at the times of COVID-19 pandemic
por: Diamand, Romain, et al.
Publicado: (2020)